K. Kroeze-Jansema

Genome‐wide linkage scan in Dutch hereditary non‐BRCA1/2 breast cancer families identifies 9q21‐22 as a putative breast cancer susceptibility locus

J. Houwing-Duistermaat, P. Devilee, H. Meijers-Heijboer, 2008, Genes, chromosomes & cancer.

4.1. CHARACTERIZATION OF FAMILIAL NON-BRCA1/2 BREAST TUMORS BY LOSS OF HETEROZYGOSIT Y AND IMMUNOPHENOT YPING

P. Devilee, H. Meijers-Heijboer, H. Morreau, 2008 .

Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping

J. Houwing-Duistermaat, P. Devilee, H. Meijers-Heijboer, 2006, Clinical Cancer Research.

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

J. Klijn, P. Devilee, H. Meijers-Heijboer, 2003, Cancer research.

A genome wide linkage search for breast cancer susceptibility genes

S. Seal, M. Stratton, N. Rahman, 2006, Genes, chromosomes & cancer.

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

J. Klijn, K. Pooley, C. Jacobi, 2007, Breast Cancer Research.

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium

S. Seal, M. Stratton, N. Rahman, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Only about 25% of familial breast cancer is explained by mutations in brca1 and brca2, fewer by moderate penetrance genes like p53, pten, chek2, atm and palb2 and an unknown fraction by common variants of genes with low penetrance

P. Devilee, H. Meijers-Heijboer, L. Wessels, 2008 .

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2

P. Devilee, H. Meijers-Heijboer, N. Hoogerbrugge, 2005, Breast Cancer Research.